
Novavax Reports Vaccine 90% Effective; Supply Questions Remain
Voice of America
Another highly effective vaccine is poised to join the fight against COVID-19.
But its impact may be blunted by supply issues. The manufacturer expected to produce the bulk of the doses is in India, where the government has banned vaccine exports. Biotech company Novavax announced Monday that its vaccine was 100% effective in preventing severe cases of COVID-19 and 90% effective in preventing any form of the disease in a clinical trial in the United States and Mexico. The company has an agreement to sell 350 million doses to COVAX, the World Health Organization-backed program to improve equitable vaccine access globally. It expects to start delivering shots in the third quarter of 2021, pending approval from regulators.
Callum Ganz, 17, center, gives a pre-show pep talk to castmates in 'Crazy for You' on opening night as the Theatre Palisades Youth group returns to the stage after losing their theater in the Palisades fire, in Los Angeles, Feb. 28, 2025. A Theatre Palisades stands next to the theater destroyed by the Palisades Fire, in the Pacific Palisades neighborhood of Los Angeles, Calif., Jan. 25, 2025.

Staff at the Mission Control outside Austin, Texas celebrating as lunar lander Blue Ghost touches down on the moon with a special delivery for NASA, March 2, 2025. (NASA/Firefly Aerospace via AP) Private lunar lander Blue Ghost after touching down on the moon with a special delivery for NASA, March 2, 2025. (NASA/Firefly Aerospace via AP)

Staff at the Mission Control outside Austin, Texas celebrating as lunar lander Blue Ghost touches down on the moon with a special delivery for NASA, March 2, 2025. (NASA/Firefly Aerospace via AP) Private lunar lander Blue Ghost after touching down on the moon with a special delivery for NASA, March 2, 2025. (NASA/Firefly Aerospace via AP)